193 related articles for article (PubMed ID: 18385396)
1. How should nephrologists approach gadolinium-based contrast imaging in patients with kidney disease?
Perazella MA
Clin J Am Soc Nephrol; 2008 May; 3(3):649-51. PubMed ID: 18385396
[No Abstract] [Full Text] [Related]
2. Risk for nephrogenic systemic fibrosis with gadoteridol (ProHance) in patients who are on long-term hemodialysis.
Reilly RF
Clin J Am Soc Nephrol; 2008 May; 3(3):747-51. PubMed ID: 18287249
[TBL] [Abstract][Full Text] [Related]
3. The role of gadolinium in triggering nephrogenic systemic fibrosis/nephrogenic fibrosing dermopathy.
Solomon GJ; Rosen PP; Wu E
Arch Pathol Lab Med; 2007 Oct; 131(10):1515-6. PubMed ID: 17922586
[No Abstract] [Full Text] [Related]
4. Nephrogenic systemic fibrosis in Japan: advisability of keeping the administered dose as low as possible.
Tsushima Y; Takahashi-Taketomi A; Endo K
Radiology; 2008 Jun; 247(3):915-6. PubMed ID: 18487548
[No Abstract] [Full Text] [Related]
5. [Gadolinium: a true problem for the nephrologists?].
Balducci A; Tamburrini O
G Ital Nefrol; 2008; 25(1):3-4. PubMed ID: 18264906
[No Abstract] [Full Text] [Related]
6. Response to the FDA's May 23, 2007, nephrogenic systemic fibrosis update.
Kanal E; Broome DR; Martin DR; Thomsen HS
Radiology; 2008 Jan; 246(1):11-4. PubMed ID: 17855656
[No Abstract] [Full Text] [Related]
7. [Nephrotoxicity of contrast media in magnetic resonance tomography (MRI)].
Heuck A; Reiser M
Internist (Berl); 1997 Dec; 38(12):1234-5. PubMed ID: 9465330
[No Abstract] [Full Text] [Related]
8. Gadolinium contrast may be risky in kidney disease.
Thomson PC; Collidge TA; Mark PB; Traynor JP
BMJ; 2007 Jun; 334(7608):1335-6. PubMed ID: 17599982
[No Abstract] [Full Text] [Related]
9. [Nephrogenic systemic fibrosis].
Cavallini L; Abaterusso C; Bedogna V; Pertica N; Loschiavo C; Lupo A
G Ital Nefrol; 2008; 25(1):14-20. PubMed ID: 18264914
[TBL] [Abstract][Full Text] [Related]
10. Imaging patients with chronic kidney disease: CIN or NSF?
Thomsen HS
Radiol Med; 2007 Aug; 112(5):621-5. PubMed ID: 17653629
[TBL] [Abstract][Full Text] [Related]
11. [The Grenelle of MR contrast agents?].
Clément O
J Radiol; 2007 Nov; 88(11 Pt 1):1663. PubMed ID: 18065924
[No Abstract] [Full Text] [Related]
12. Are patients with moderate renal failure at risk for developing nephrogenic systemic fibrosis?
Saab G; Abu-Alfa A
Radiology; 2007 Sep; 244(3):930-1; author reply 931-2. PubMed ID: 17709844
[No Abstract] [Full Text] [Related]
13. Gadolinium-containing magnetic resonance imaging contrast and nephrogenic systemic fibrosis: a case-control study.
Kallen AJ; Jhung MA; Cheng S; Hess T; Turabelidze G; Abramova L; Arduino M; Guarner J; Pollack B; Saab G; Patel PR
Am J Kidney Dis; 2008 Jun; 51(6):966-75. PubMed ID: 18501784
[TBL] [Abstract][Full Text] [Related]
14. Nephrogenic systemic fibrosis: A serious late adverse reaction to gadodiamide.
Thomsen HS
Eur Radiol; 2006 Dec; 16(12):2619-21. PubMed ID: 17061066
[No Abstract] [Full Text] [Related]
15. Is there a causal relation between the administration of gadolinium based contrast media and the development of nephrogenic systemic fibrosis (NSF)?
Thomsen HS; Morcos SK; Dawson P
Clin Radiol; 2006 Nov; 61(11):905-6. PubMed ID: 17018301
[No Abstract] [Full Text] [Related]
16. Nephrogenic systemic fibrosis: is gadolinium the missing piece to the puzzle?
Bennett LK; Garrett AL
Cutis; 2008 May; 81(5):421-6. PubMed ID: 18543594
[TBL] [Abstract][Full Text] [Related]
17. Gadoteridol-induced anaphylaxis - not a class allergy.
Galera C; Pur Ozygit L; Cavigioli S; Bousquet PJ; Demoly P
Allergy; 2010 Jan; 65(1):132-4. PubMed ID: 19796195
[No Abstract] [Full Text] [Related]
18. Imaging patients with kidney disease: how do we approach contrast-related toxicity?
Perazella MA; Reilly RF
Am J Med Sci; 2011 Mar; 341(3):215-21. PubMed ID: 21139495
[TBL] [Abstract][Full Text] [Related]
19. Nephrogenic systemic fibrosis following gadolinium administration.
Tammaro A; Narcisi A; Tuchinda P; Sina B
Cutis; 2015 Jul; 96(1):E23-5. PubMed ID: 26244362
[No Abstract] [Full Text] [Related]
20. Type of MRI contrast, tissue gadolinium, and fibrosis.
Do C; Barnes JL; Tan C; Wagner B
Am J Physiol Renal Physiol; 2014 Oct; 307(7):F844-55. PubMed ID: 25100280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
